Technology | 2015.11.04
MENSIA Technologies Receives €3.6 Million from the EU to Develop NEWROFEED, a Non-Invasive, Non-Drug Solution for the Treatment of ADHD in Children
PARIS & RENNES, France--(BUSINESS WIRE)--MENSIA Technologies, a company developing non-invasive medical devices for the care of the Central Nervous System, announced today that it has been awarded €3.6 million from the EU as part of the H2020/SME Instrument call for projects, for its project NEWROFEED. The objective is to develop an original and non-invasive therapeutic medical device for children with ADHD. Developed in close collaboration with neuroscientists and clinicians, the personalized
For more information, please visit
http://www.businesswire.com/news/home/20[...]E2%82%AC3.6-Million-EU-Develop
